Oversold

MMED

ValuationN/A
Cash flow & growthN/A
Upside potentialN/A
Risk potentialN/A

Valuation

The valuation score compares today’s PE with recent history and similar earnings periods. Stronger growth supports a higher valuation; weaker growth lowers it. Earnings that are difficult to compare receive less weight.

Cash flow & growth

The business score reflects revenue and earnings growth, profit margins and free cash flow. Recent results show whether the business is improving or weakening. Measures must fit the business; incomplete or older data receives less weight.

Favorable scenario

Reliable data is insufficient to calculate upside.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Reliable data is insufficient to calculate downside.

This is a scenario based on our model, not a forecast or probability.

MMED vs Historical averages

MetricCurrentAverageRelative
Loading historical comparisons…

MMED Forward outlook

MetricOutlook
Forward valuation--
Forward earnings--
Forward revenueGrowth
Forward profitabilityStrongly expanding
Analyst coverageModerate
Estimate dispersionWide

MMED’s available outlook is mixed, though analysts differ widely on the estimates.

MMED PE Valuation

Loading pe valuation table…

This table applies MMED's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

MMED Earnings Per Share

Loading earnings per share…

This chart tracks MMED's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

MMED Quarterly Revenue

Loading quarterly revenue…

This chart tracks MMED's quarterly revenue over time and shows how sales are changing from year to year.

MMED Free Cash Flow

Loading free cash flow…

This chart tracks MMED's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

MMED Total Shares

Loading shares over time…

This chart tracks changes in MMED's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

MMED Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

MMED PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares MMED's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

MMED Weekly Price

Loading weekly price…

This chart uses MMED's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

MMED Weekly Moving Averages

Loading weekly moving averages…

This chart compares MMED's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

MMED Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.

NVO

Valuation50/ 100
Cash flow & growth55/ 100
Upside potential38/ 100
Risk potential39/ 100

NVO's valuation appears fair, fundamentals are somewhat mixed and expected margin pressure limits the outlook, though analyst coverage is limited.

Score change since last week

The score rose 11 points, mainly due to valuation and price changes. Price rose 2.2%, from $45.61 to $46.60.

Valuation and price changes added 10.9 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Valuation stays neutral because earnings are difficult to compare across periods. Business trends, outlook and financial risk still contribute to the overall score.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +5.6%, earnings +5%, operating margin -2.6 percentage points. Free cash flow is 14.9% of revenue. The business score is 55.4/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Weaker business results limit upside support. Price history provides the reference because earnings are difficult to compare.

The calculation starts with the stock’s typical weekly price movements, adjusted for business performance and outlook. Unusually large jumps have less influence. The result is 24% upside, or about $53.41.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Historical price swings are the main risk driver, even without a sharp profit decline.

The stock’s historical price swings drive this figure; the separate operating stress is 28.7%. Price history and operating stress provide the reference because comparable earnings do not support a future PE target. Operating stress reflects revenue, earnings, margins, outlook and relevant debt exposure. The larger stress gives 38.5% downside, or about $26.49, with a 15% minimum.

This is a scenario based on our model, not a forecast or probability.

NVO vs Historical averages

MetricCurrentAverageRelative
PE11x28x62% lower
PE percentile5.45089% lower
EPS$4.09$2.3674% higher
FCF$7.6B$8.5B10% lower
Loading historical comparisons…

NVO’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.

NVO Forward outlook

MetricOutlook
Forward valuationStrongly improving
Forward earningsStrong growth
Forward revenueDecline
Forward profitabilityStrongly contracting
Analyst coverageLimited
Estimate dispersionModerate

NVO’s outlook is mixed, with declining sales expectations a concern.

NVO PE Valuation

Loading pe valuation table…

This table applies NVO's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

NVO Earnings Per Share

Loading earnings per share…

This chart tracks NVO's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

NVO Quarterly Revenue

Loading quarterly revenue…

This chart tracks NVO's quarterly revenue over time and shows how sales are changing from year to year.

NVO Free Cash Flow

Loading free cash flow…

This chart tracks NVO's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

NVO Total Shares

Loading shares over time…

This chart tracks changes in NVO's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

NVO Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

NVO PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares NVO's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

NVO Weekly Price

Loading weekly price…

This chart uses NVO's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

NVO Weekly Moving Averages

Loading weekly moving averages…

This chart compares NVO's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

NVO Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.